Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis

M. Bezdicek, M. Lengerova, D. Ricna, B. Weinbergerova, I. Kocmanova, P. Volfova, L. Drgona, M. Poczova, J. Mayer, Z. Racil,

. 2016 ; 54 (7) : 714-24. [pub] 20160509

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17013869

Despite advances in the treatment of invasive fungal diseases (IFD), mortality rates remain high. Moreover, due to the expanding spectrum of causative agents, fast and accurate pathogen identification is necessary. We designed a panfungal polymerase chain reaction (PCR), which targets the highly variable ITS2 region of rDNA genes and uses high resolution melting analysis (HRM) for subsequent species identification. The sensitivity and specificity of this method was tested on a broad spectrum of the most clinically important fungal pathogens including Aspergillus spp., Candida spp. and mucormycetes. Despite the fact that fluid from bronchoalveolar lavage (BAL) is one of the most frequently tested materials there is a lack of literature sources aimed at panfungal PCR as an IFD diagnostic tool from BAL samples. The applicability of this method in routine practice was evaluated on 104 BAL samples from immunocompromised patients. Due to high ITS region variability, we obtained divergent melting peaks for different fungal species. Thirteen out of 18 patients with proven or probable IFD were positive. Therefore, the sensitivity, specificity, positive predictive value and negative predictive value of our method were 67%, 100%, 100%, and 94%, respectively. In our assay, fungal pathogens identification is based on HRM, therefore omitting the expensive and time consuming sequencing step. With the high specificity, positive and negative predictive values, short time needed to obtain a result, and low price, the presented assay is intended to be used as a quick screening method for patients at risk of IFD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013869
003      
CZ-PrNML
005      
20170427104637.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/mmy/myw032 $2 doi
035    __
$a (PubMed)27161789
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bezdicek, Matej $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    10
$a Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis / $c M. Bezdicek, M. Lengerova, D. Ricna, B. Weinbergerova, I. Kocmanova, P. Volfova, L. Drgona, M. Poczova, J. Mayer, Z. Racil,
520    9_
$a Despite advances in the treatment of invasive fungal diseases (IFD), mortality rates remain high. Moreover, due to the expanding spectrum of causative agents, fast and accurate pathogen identification is necessary. We designed a panfungal polymerase chain reaction (PCR), which targets the highly variable ITS2 region of rDNA genes and uses high resolution melting analysis (HRM) for subsequent species identification. The sensitivity and specificity of this method was tested on a broad spectrum of the most clinically important fungal pathogens including Aspergillus spp., Candida spp. and mucormycetes. Despite the fact that fluid from bronchoalveolar lavage (BAL) is one of the most frequently tested materials there is a lack of literature sources aimed at panfungal PCR as an IFD diagnostic tool from BAL samples. The applicability of this method in routine practice was evaluated on 104 BAL samples from immunocompromised patients. Due to high ITS region variability, we obtained divergent melting peaks for different fungal species. Thirteen out of 18 patients with proven or probable IFD were positive. Therefore, the sensitivity, specificity, positive predictive value and negative predictive value of our method were 67%, 100%, 100%, and 94%, respectively. In our assay, fungal pathogens identification is based on HRM, therefore omitting the expensive and time consuming sequencing step. With the high specificity, positive and negative predictive values, short time needed to obtain a result, and low price, the presented assay is intended to be used as a quick screening method for patients at risk of IFD.
650    _2
$a bronchoalveolární lavážní tekutina $x mikrobiologie $7 D001992
650    _2
$a DNA fungální $x chemie $x genetika $7 D004271
650    _2
$a mezerníky ribozomální DNA $x chemie $x genetika $7 D021903
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a houby $x klasifikace $x genetika $x izolace a purifikace $7 D005658
650    _2
$a lidé $7 D006801
650    _2
$a plicní mykózy $x diagnóza $x mikrobiologie $7 D008172
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a diagnostické techniky molekulární $x metody $7 D025202
650    _2
$a polymerázová řetězová reakce $x metody $7 D016133
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a časové faktory $7 D013997
650    12
$a tranzitní teplota $7 D044366
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lengerova, Martina $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic mlengerova@fnbrno.cz.
700    1_
$a Ricna, Dita $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Weinbergerova, Barbora $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Kocmanova, Iva $u Department of Clinical Microbiology, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Volfova, Pavlina $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Drgona, Lubos $u Department of Oncohematology, Comenius University in Bratislava and National Cancer Institute, Bratislava, Slovakia.
700    1_
$a Poczova, Miroslava $u Department of Mycology, HPL Ltd., Bratislava, Slovakia.
700    1_
$a Mayer, Jiri $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Racil, Zdenek $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00005131 $t Medical mycology $x 1460-2709 $g Roč. 54, č. 7 (2016), s. 714-24
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27161789 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427104957 $b ABA008
999    __
$a ok $b bmc $g 1200334 $s 974647
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 54 $c 7 $d 714-24 $e 20160509 $i 1460-2709 $m Medical mycology $n Med Mycol $x MED00005131
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options